Medscape Conference Coverage, based on selected sessions at the:
2nd Annual Multidisciplinary Prostate Cancer Symposium
February 24 - 26, 2006, San Francisco, California

This activity is not sanctioned by, nor a part of, the 2nd Annual Multidisciplinary Prostate Cancer Symposium.


Also On This Page:Expert Interviews
Topic Overviews
Planning and Assessment of New Prostate Cancer Therapies CME
Physicians - up to 1.0 AMA PRA Category 1 credits
Improving Prognosis for Patients With Early Prostate Cancer: Innovations in Surgery, Radiotherapy, and Immunotherapy
Hossein Jadvar, MD, PhD
Using Molecular Pathways to Select Targeted Therapies for Prostate Cancer
Hossein Jadvar, MD, PhD
Imaging of Prostate Cancer: Many Options, Paltry Progress
Hossein Jadvar, MD, PhD

Late-Stage Prostate Cancer: The Emergence of Promising Interventions CME
Physicians - up to 1.0 AMA PRA Category 1 credits
Chemotherapy and Novel Agents for Patients With Advanced Prostate Cancer: New Developments
Robert Dreicer, MD, FACP
Hormonal and Bone-Targeted Therapies for Patients With Advanced Prostate Cancer: Recent Advances
Robert Dreicer, MD, FACP
Balancing Interventions With Quality of Life in Advanced Prostate Cancer
Hossein Jadvar, MD, PhD

Expert Interviews
Chemotherapy for Advanced Prostate Cancer: An Expert Interview With Dr. Howard I. Scher
In this Expert Interview from the Prostate Cancer Symposium, Dr. Howard I. Scher reviews new chemotherapy approaches that are extending survival for patients with advanced prostate cancer.

 
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the 2nd Annual Multidisciplinary Prostate Cancer Symposium. These materials and the related activity are not sanctioned by the 2nd Annual Multidisciplinary Prostate Cancer Symposium or the commercial supporter of the conference, and do not constitute an official part of that conference.
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2006 Medscape.

 


Sanofi Aventis

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.